CHAPTER 19 (Lippincott)

Total Page:16

File Type:pdf, Size:1020Kb

Load more

CHAPTER 19 (Lippincott) Amino Acids - Disposal of Nitrogen OVERALL NITROGEN METABOLISM Amino acid catabolism is part of the larger process of the metabolism of nitrogen-containing molecules. Nitrogen enters the body in a variety of compounds present in food, the most important being amino acids contained in dietary protein. Nitrogen leaves the body as urea, ammonia, and other products derived from amino acid metabolism. This chapter describes how the nitrogen of amino acids is converted to urea and the rare disorders that accompany defects in urea biosynthesis. BIOMEDICAL IMPORTANCE Formation and elimination in the body Ammonia is a metabolic product of amino acid deamination catalyzed by enzymes. Ammonia is quickly converted to urea, which is much less toxic, particularly less basic. This urea is a major component of the dry weight of urine. The liver converts ammonia to urea through a series of reactions known as the urea cycle. Liver dysfunction, such as that seen in cirrhosis, may lead to elevated amounts of ammonia in the blood (hyperammonemia). Likewise, defects in the enzymes responsible for the urea cycle, leads to this disorder. It causes confusion and coma, neurological problems, and aciduria (acid in the urine). While ammonia, derived mainly from the α-amino nitrogen of amino acids, is highly toxic, tissues convert ammonia to the amide nitrogen of nontoxic GLUTAMINE. Subsequent deamination of glutamine in the liver releases ammonia, which is then converted to nontoxic urea. If liver function is compromised, as in cirrhosis or hepatitis, elevated blood ammonia levels generate clinical signs and symptoms. Rare metabolic disorders involve each of the five urea cycle enzymes. PROTEIN TURNOVER OCCURS IN ALL FORMS OF LIFE The continuous degradation and synthesis of cellular proteins occur in all forms of life. Each day humans turn over 1–2% of their total body protein, principally muscle protein. High rates of protein degradation occur in tissues undergoing structural rearrangement—eg, uterine tissue during pregnancy or skeletal muscle in starvation. Of the liberated amino acids, approximately 75% are reutilized. The excess nitrogen forms urea. Since excess amino acids are not stored, those not immediately incorporated into new protein are rapidly degraded. Most proteins in the body are constantly being synthesized and then degraded, permitting the removal of abnormal or unneeded proteins. For many proteins, regulation of synthesis 1 determines the concentration of protein in the cell, with protein degradation assuming a minor role. For other proteins, the rate of synthesis is constitutive, that is, relatively constant, and cellular levels of the protein are controlled by selective degradation. Rate of turnover: In healthy adults, the total amount of protein in the body remains constant, because the rate of protein synthesis is just sufficient to replace the protein that is degraded. This process, called protein turnover, leads to the hydrolysis and resynthesis of 300–400 g of body protein each day. The rate of protein turnover varies widely for individual proteins. Short-lived proteins (for example, many regulatory proteins and misfolded proteins) are rapidly degraded, having half-lives measured in minutes or hours. Long-lived proteins, with half-lives of days to weeks, constitute the majority of proteins in the cell. Structural proteins, such as collagen, are metabolically stable, and have half-lives measured in months or years. PROTEASES & PEPTIDASES DEGRADE PROTEINS TO AMINO ACIDS The susceptibility of a protein to degradation is expressed as its half-life (t1/2),, the time required to lower its concentration to half the initial value. Half-lives of liver proteins range from under 30 minutes to over 150 hours. The half-life of a protein is influenced by the nature of the N- terminal residue. For example, proteins that have serine as the N-terminal amino acid are long-lived, with a half-life of more than 20 hours. In contrast, proteins with aspartate as the N-terminal amino acid have a half-life of only 3 minutes. Additionally, proteins rich in sequences containing proline, glutamate, serine, and threonine (called PEST sequences after the one-letter designations for these amino acids) are rapidly degraded and, therefore, exhibit short intracellular half-lives 1. Typical “housekeeping” enzymes have t1/2 values of over 100 hours. 2. Many key regulatory enzymes have a t1/2 of 0.5–2 hours. 3. Degradation of circulating peptides such as hormones follows loss of a sialic acid moiety from the nonreducing ends of their oligosaccharide chains. Asialoglycoproteins are internalized by liver cell asialoglycoprotein receptors and degraded by lysosomal proteases termed cathepsins. 4. Extracellular, membrane-associated, and long-lived intracellular proteins are degraded in lysosomes by ATP-independent processes. 5. Degradation of abnormal and other short-lived proteins occurs in the cytosol and requires ATP and ubiquitin. Ubiquitin, so named because it is present in all eukaryotic cells, is a small (8.5 kDa) protein that targets many intracellular proteins for degradation. Degradation occurs in a multicatalytic complex of proteases known as the proteasome. 2 PROTEIN DEGRADATION: There are two major enzyme systems responsible for degrading damaged or unneeded proteins: 1. The ATP-dependent UBIQUITIN-PROTEASOME SYSTEM of the cytosol, Ubiquitin- proteasome proteolytic pathway: Proteins selected for degradation by the ubiquitin- proteasome system are first covalently attached to ubiquitin, a small, globular, non-enzymic protein. Ubiquitination of the target substrate occurs through linkage of the α-carboxyl group of the C-terminal glycine of ubiquitin to the ε-amino group of a lysine on the protein substrate by a three-step, enzyme-catalyzed, ATP-dependent process. The consecutive addition of ubiquitin moieties generates a polyubiquitin chain. Proteins tagged with ubiquitin are then recognized by a large, barrel-shaped, macromolecular, proteolytic complex called a proteasome, which functions like a garbage disposal . The proteasome unfolds, deu- biquitinates, and cuts the target protein into fragments that are then further degraded to amino acids, which enter the amino acid pool. [Note: The ubiquitins are recycled.] It is noteworthy that the selective degradation of proteins by the ubiquitin-proteosome complex (unlike simple hydrolysis by proteolytic enzymes) requires energy in the form of ATP. 2.The ATP-independent DEGRADATIVE ENZYME SYSTEM OF THE LYSOSOMES. Proteasomes degrade mainly endogenous proteins, that is, proteins that were synthesized within the cell. Lysosomal enzymes (acid hydrolases, degrade primarily extra-cellular proteins, such as plasma proteins that are taken into the cell by endocytosis, and cell-surface membrane proteins that are used in receptor-mediated endocytosis. These two systems yield AMINO ACIDS for further catabolism. Chemical signals for protein degradation: Because proteins have different half-lives, it is clear that protein degradation cannot be random, but rather is influenced by some structural aspect of the protein. For example, some proteins that have been chemically altered by oxidation or tagged with ubiquitin are preferentially degraded. The half-life of a protein is influenced by the nature of the N-terminal residue. For example, proteins that have serine as the N-terminal amino acid are long-lived, with a half-life of more than 20 hours. In contrast, proteins with aspartate as the N-terminal amino acid have a half-life of only 3 minutes. Additionally, proteins rich in sequences containing proline, glutamate, serine, and threonine (called PEST sequences after the one-letter designations for these amino acids) are rapidly degraded and, therefore, exhibit short intracellular half-lives. CATABOLISM OF AMINO ACIDS Unlike fats and carbohydrates, amino acids are not stored by the body, that is, no protein exists whose sole function is to maintain a supply of amino acids for future use. Therefore, amino acids must be obtained from the diet, synthesized de novo, or produced from normal protein degradation. Any amino acid in excess of the biosynthetic needs of the cell are rapidly degraded. 3 1. The first phase of catabolism involves the removal of the α-amino groups (usually by transamination and subsequent oxidative deamination), forming ammonia and the corresponding α-keto acid—the “carbon skeletons” of amino acids. A portion of the free ammonia is excreted in the urine, but most is used in the synthesis of urea, which is quantitatively the most important route for disposing off nitrogen from the body. 2. In the second phase of amino acid catabolism, the carbon skeletons are converted to common intermediates of energy producing, metabolic pathways. These compounds can be metabolized to CO2 and water, glucose, fatty acids, or ketone bodies by the central path-ways of metabolism. The role of body proteins in these transformations involves two important concepts: the amino acid pool and protein turnover. THE AMINO ACID POOL Free amino acids are present throughout the body, for example, in cells, blood, and the extracellular fluids. For the purpose of this discussion, envision all these amino acids as if they belonged to a single entity, called the amino acid pool. This pool is supplied by three sources: 1) amino acids provided by the degradation of body proteins, 2) amino acids derived from dietary protein, 3) synthesis of nonessential amino acids from simple intermediates of metabolism Conversely, the amino pool is depleted by three routes: 1) synthesis of body protein 2) amino acids consumed as precursors of essential nitrogen-containing small molecules, 3) conversion of amino acids to glucose, glycogen, fatty acids, ketone bodies, or CO2 + H2O). Although the amino acid pool is small (comprised of about 90–100 g of amino acids) in comparison with the amount of protein in the body (about 12 kg in a 70-kg man), it is conceptually at the center of whole-body nitrogen metabolism TRANSPORT OF AMINO ACIDS INTO CELLS The concentration of free amino acids in the extracellular fluid is significantly lower than that within the cells of the body.
Recommended publications
  • Novel Neuroprotective Compunds for Use in Parkinson's Disease

    Novel Neuroprotective Compunds for Use in Parkinson's Disease

    Novel neuroprotective compounds for use in Parkinson’s disease A thesis submitted to Kent State University in partial Fulfillment of the requirements for the Degree of Master of Science By Ahmed Shubbar December, 2013 Thesis written by Ahmed Shubbar B.S., University of Kufa, 2009 M.S., Kent State University, 2013 Approved by ______________________Werner Geldenhuys ____, Chair, Master’s Thesis Committee __________________________,Altaf Darvesh Member, Master’s Thesis Committee __________________________,Richard Carroll Member, Master’s Thesis Committee ___Eric_______________________ Mintz , Director, School of Biomedical Sciences ___Janis_______________________ Crowther , Dean, College of Arts and Sciences ii Table of Contents List of figures…………………………………………………………………………………..v List of tables……………………………………………………………………………………vi Acknowledgments.…………………………………………………………………………….vii Chapter 1: Introduction ..................................................................................... 1 1.1 Parkinson’s disease .............................................................................................. 1 1.2 Monoamine Oxidases ........................................................................................... 3 1.3 Monoamine Oxidase-B structure ........................................................................... 8 1.4 Structural differences between MAO-B and MAO-A .............................................13 1.5 Mechanism of oxidative deamination catalyzed by Monoamine Oxidases ............15 1 .6 Neuroprotective effects
  • Development of a System of High Ornithine and Citrulline Production by a Plant-Derived Lactic Acid Bacterium, Weissella Confusa K-28

    Development of a System of High Ornithine and Citrulline Production by a Plant-Derived Lactic Acid Bacterium, Weissella Confusa K-28

    Development of a system of high ornithine and citrulline production by a plant-derived lactic acid bacterium, Weissella confusa K-28 㸦᳜≀⏤᮶ங㓟⳦ :HLVVHOODFRQIXVD. ࡟࠾ࡅࡿ ࢜ࣝࢽࢳࣥཬࡧࢩࢺࣝࣜࣥ㧗⏕⏘ࢩࢫࢸ࣒ࡢᵓ⠏㸧 Md Rakhimuzzaman Student ID: D164180 Supervisor: Prof. Masanori Sugiyama Department of Probiotic Science for Preventive Medicine Graduate School of Biomedical and Health Sciences Hiroshima University, Japan 2019 ABBREVIATIONS ADI arginine deiminase AUC area under curve BLAST basic local alignment search tool CK carbamate kinase dNTP deoxyribonucleotide triphosphate DDBJ DNA Data Bank of Japan EDTA ethylenediamine tetra-acetic acid EtOH ethanol EPS exopolysaccharide GABA gamma-aminobutyric acid GRAS generally recognized as safe HPLC high performance liquid chromatography LAB lactic acid bacteria Lb. Lactobacillus OD optical density OTC ornithine carbamoyltransferase PITC phenyl isothiocyanate TAE tris-acetate-ethylenediamine tetra-acetic acid TE tris-ethylenediamine tetra-acetic acid TEA triethylamine Tris tris(hydroxymethyl)aminomethane rDNA ribosomal deoxyribonucleic acid RT-PCR reverse transcription polymerase chain reaction CONTENTS INTRODUCTION 1-17 OBJECTIVES 18 MATERIALS AND METHODS 19-34 RESULTS 35-57 DISCUSSIONS 58-65 CONCLUSION 66-67 ACKNOWLEDGEMENTS 68 REFERENCES 69-84 INTRODUCTION Lactic acid bacteria (LAB) are an order of gram-positive, acid-tolerant, generally nonsporulating, non-respiring, either rod-shaped or spherical microorganisms. Since LAB lack the ability of synthesizing porphyrins (heme, and components of respiratory chains) (Pessione et al, 2010), the bacteria can not generate ATP without external heme supplementation (Pessione et al, 2010). The LAB strains can only obtain ATP by fermentation, usually they generate the ATP from some sugars. Because LAB do not use oxygen for energy production, the bacteria easily grow under anaerobic conditions, but they can also grow in presence of oxygen.
  • Metabolic Reprogramming in Prostate Cancer

    Metabolic Reprogramming in Prostate Cancer

    www.nature.com/bjc REVIEW ARTICLE Metabolic reprogramming in prostate cancer Fahim Ahmad 1,2, Murali Krishna Cherukuri2 and Peter L. Choyke1 Although low risk localised prostate cancer has an excellent prognosis owing to effective treatments, such as surgery, radiation, cryosurgery and hormone therapy, metastatic prostate cancer remains incurable. Existing therapeutic regimens prolong life; however, they are beset by problems of resistance, resulting in poor outcomes. Treatment resistance arises primarily from tumour heterogeneity, altered genetic signatures and metabolic reprogramming, all of which enable the tumour to serially adapt to drugs during the course of treatment. In this review, we focus on alterations in the metabolism of prostate cancer, including genetic signatures and molecular pathways associated with metabolic reprogramming. Advances in our understanding of prostate cancer metabolism might help to explain many of the adaptive responses that are induced by therapy, which might, in turn, lead to the attainment of more durable therapeutic responses. British Journal of Cancer https://doi.org/10.1038/s41416-021-01435-5 BACKGROUND Several tools have been designed to assess metabolism without Cellular metabolism involves complex biochemical processes disturbing the system. Advances in nuclear magnetic resonance through which specific nutrients are consumed. Carbohydrates, and mass spectroscopy have helped to quantify the carbon influx fatty acids and amino acids are the main source of nutrients for of the central metabolic pathways (e.g. TCA cycle, glycolysis and energy homeostasis and macromolecular synthesis. They are the pentose phosphate pathway) in mammalian systems, and this main constituent of core metabolic pathways that can be approach has been instrumental in demonstrating that the classified as anabolic, catabolic or waste producing (Fig.
  • Amino Acid Degradation; Urea Cycle

    Amino Acid Degradation; Urea Cycle

    Amino acid degradation; urea cycle Kristina Mlinac Jerković [email protected] In animals, amino acids undergo oxidative degradation in three different metabolic circumstances: 1. During the normal synthesis and degradation of cellular proteins, some amino acids that are released from protein breakdown and are not needed for new protein synthesis undergo oxidative degradation. 2. When a diet is rich in protein and the ingested amino acids exceed the body’s needs for protein synthesis, the surplus is catabolized; amino acids cannot be stored. 3. During starvation or in uncontrolled diabetes mellitus, when carbohydrates are either unavailable or not properly utilized, cellular proteins are used as fuel. Metabolic fates of amino groups - The metabolism of nitrogen-containing molecules such as proteins and nucleic acids differs significantly from that of carbohydrates and lipids. - Whereas the latter molecules can be stored and mobilized as needed for biosynthetic reactions or for energy generation, there is no nitrogen-storing molecule (one exception to this rule is storage protein in seeds). - Organisms must constantly replenish their supply of usable nitrogen to replace organic nitrogen that is lost in catabolism. For example, animals must have a steady supply of amino acids in their diets to replace the nitrogen excreted as urea, uric acid, and other nitrogenous waste products. - Since excess dietary amino acids are neither stored for future use nor excreted, they are converted to common metabolic intermediates such as pyruvate, oxaloacetate, acetyl-CoA, and α-keto-glutarate. - Consequently, amino acids are also precursors of glucose, fatty acids, and ketone bodies and are therefore metabolic fuels.
  • Protein Metabolism and It's Disorders

    Protein Metabolism and It's Disorders

    Protein Metabolism and it’s Disorders (Course : M.Sc. Zoology) Course Code: ZOOL 4008 (Biochemistry and Metabolism), Semester –II Dr. Shyam Babu Prasad Assistant Professor Department of Zoology Mahatma Gandhi Central University (MGCU), Motihari-845401 (Bihar) Email: [email protected] Important facts of the Protein Metabolism •Proteins metabolism referred as synthesis of protein from Amino acids (Anabolism) and breakdown of proteins (Catabolism). •In the Unit II, we discussed the synthesis (Anabolism) of various form of the proteins from different amino acids. • Here we mainly focused on the Catabolism of the protein, which is integral part of metabolism of the nitrogen-containing molecules. • Nitrogen enters in to the body in various form of compounds that is present in food, the most important is amino acids (as dietary food). • During Protein/amino acid metabolism (Catabolism), Nitrogen leaves the body as urea, ammonia, and in form of other derivatives. • The Catabolism of the protein depends on the amino acid pool and protein turnover (the rate of protein synthesis and degradation is equal). • The amino acids present in through out of the body (cells, blood, and the extracellular fluids etc) is called amino acid pools. It is maintained by following factors as represented in below diagram: Body protein Dietary degradation Protein 400gm/day 600gm/day Supplied Amino acid pool Depleted Synthesis of Remaining Synthesis of Glucose, Synthesis of amino acids Nitrogen containing Glycogen, the Body burned as compound like Ketone Proteins
  • Transaminations and Urea Cycle

    Transaminations and Urea Cycle

    • Thus far, you have studied various pathways including, Glycolysis, Gluconeogenesis, synthesis and degradation of fatty acids, Pentose phosphate pathway, glycogen synthesis and degradation, Monosaccharides etc. Now we will study the metabolism of amino acids which contribute significantly to the generation of metabolic energy. carnivores 90% herbivores very little. First lets begin by understanding how we get rid of Nitrogen from our bodies, so lets look at the Urea cycle. 1 α Amino group keeps amino acids safe from oxidative breakdown. Removal of this group is essential for energy production it is an obligatory step for catabolism. Nitrogen can then be incorporated or excreted.This is done through transamination or oxidative deamination, provide amonia and aspartate sources for the Urea cycle. Transamination is funneled through glutamate. This is done through the transfer of the α amino group to α ketoglutarate. Product α-keto acid and glutamate. Alanine to pyruvate and aspartate to oxaloacetate all amino acids except lysine and threonina (lose the α amino through deamination. Glutamate dehydrogenase the oxidative deamination Glutamate only amino acid that undergoes rapid oxidative deamination (glutamate dehydrogenase NH3 + NADH), where amino groups are released as ammonia. After a meal rich in protein the levels of glutamate in liver are increased favoring amino acid degradation and formation of ammonia. Activators of this enzyme are ADP and GDP while ATP and GTP are inhibitors. This reaction occurs in the mitochondria. Ammonia can be transported to the liver from other tissues through two mechanisms that reduce the toxicity of ammonia. One through Glutamine (most tissues through, glutamine synthetase). In the liver the glutamine is converted back to glutamate (Fig.
  • ATP Structure and Function

    ATP Structure and Function

    ATP: Universal Currency of Cellular Energy All living things including plants, animals, birds, insects, humans need energy for the proper functioning of cells, tissues and other organ systems. As we are aware that green plants, obtain their energy from the sunlight, and animals get their energy by feeding on these plants. Energy acts as a source of fuel. We, humans, gain energy from the food we eat, but how are the energy produced and stored in our body. A living cell cannot store significant amounts of free energy. Excess free energy would result in an increase of heat in the cell, which would result in excessive thermal motion that could damage and then destroy the cell. Rather, a cell must be able to handle that energy in a way that enables the cell to store energy safely and release it for use only as needed. Living cells accomplish this by using the compound adenosine triphosphate (ATP). ATP is often called the “energy currency” of the cell, and, like currency, this versatile compound can be used to fill any energy need of the cell. How? It functions similarly to a rechargeable battery. When ATP is broken down, usually by the removal of its terminal phosphate group, energy is released. The energy is used to do work by the cell, usually by the released phosphate binding to another molecule, activating it. For example, in the mechanical work of muscle contraction, ATP supplies the energy to move the contractile muscle proteins. Recall the active transport work of the sodium-potassium pump in cell membranes.
  • Monoamine Oxidase Inhibitors: Promising Therapeutic Agents for Alzheimer's Disease (Review)

    Monoamine Oxidase Inhibitors: Promising Therapeutic Agents for Alzheimer's Disease (Review)

    MOLECULAR MEDICINE REPORTS 9: 1533-1541, 2014 Monoamine oxidase inhibitors: Promising therapeutic agents for Alzheimer's disease (Review) ZHIYOU CAI Department of Neurology, The Lu'an Affiliated Hospital of Anhui Medical University, Lu'an People's Hospital, Lu'an, Anhui 237005, P.R. China Received July 2, 2013; Accepted February 10, 2014 DOI: 10.3892/mmr.2014.2040 Abstract. Activated monoamine oxidase (MAO) has a critical 6. MAO activation contributes to cognitive impairment in role in the pathogenesis of Alzheimer's disease (AD), including patients with AD the formation of amyloid plaques from amyloid β peptide (Aβ) 7. Activated MAO contributes to the formation of amyloid production and accumulation, formation of neurofibrillary plaques tangles, and cognitive impairment via the destruction of cholin- 8. Is activated MAO associated with the formation of ergic neurons and disorder of the cholinergic system. Several neurofibrillary tangles? studies have indicated that MAO inhibitors improve cognitive 9. Evidence for the neuroprotective effect of MAO inhibitors deficits and reverse Aβ pathology by modulating proteolytic in AD cleavage of amyloid precursor protein and decreasing Aβ 10. Conclusions and outlook protein fragments. Thus, MAO inhibitors may be considered as promising therapeutic agents for AD. 1. Introduction Monoamine oxidase (MAO) catalyzes the oxidative deamina- Contents tion of biogenic and xenobiotic amines and has an important role in the metabolism of neuroactive and vasoactive amines in 1. Introduction the central nervous system (CNS) and peripheral tissues. The 2. Monoamine oxidase (MAO) enzyme preferentially degrades benzylamine and phenylethyl- 3. Involvement of MAO in neurodegeneration amine and targets a wide variety of specific neurotransmitters 4.
  • Laboratory Diagnostic Approaches in Metabolic Disorders

    Laboratory Diagnostic Approaches in Metabolic Disorders

    470 Review Article on Inborn Errors of Metabolism Page 1 of 14 Laboratory diagnostic approaches in metabolic disorders Ruben Bonilla Guerrero1, Denise Salazar2, Pranoot Tanpaiboon2,3 1Formerly Quest Diagnostics, Inc., Ruben Bonilla Guerrero, Rancho Santa Margarita, CA, USA; 2Quest Diagnostics, Inc., Denise Salazar and Pranoot Tanpaiboon, San Juan Capistrano, CA, USA; 3Genetics and Metabolism, Children’s National Rare Disease Institute, Washington, DC, USA Contributions: (I) Conception and design: All authors; (II) Administrative support: R Bonilla Guerrero; (III) Provision of study materials or patients: All authors; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: None; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Ruben Bonilla Guerrero. Formerly Quest Diagnostics, Inc., Ruben Bonilla Guerrero, 508 Sable, Rancho Santa Margarita, CA 92688, USA. Email: [email protected]. Abstract: The diagnosis of inborn errors of metabolism (IEM) takes many forms. Due to the implementation and advances in newborn screening (NBS), the diagnosis of many IEM has become relatively easy utilizing laboratory biomarkers. For the majority of IEM, early diagnosis prevents the onset of severe clinical symptoms, thus reducing morbidity and mortality. However, due to molecular, biochemical, and clinical variability of IEM, not all disorders included in NBS programs will be detected and diagnosed by screening alone. This article provides a general overview and simplified guidelines for the diagnosis of IEM in patients with and without an acute metabolic decompensation, with early or late onset of clinical symptoms. The proper use of routine laboratory results in the initial patient assessment is also discussed, which can help guide efficient ordering of specialized laboratory tests to confirm a potential diagnosis and initiate treatment as soon as possible.
  • Amino Acid Catabolism: Urea Cycle the Urea Bi-Cycle Two Issues

    Amino Acid Catabolism: Urea Cycle the Urea Bi-Cycle Two Issues

    BI/CH 422/622 OUTLINE: OUTLINE: Protein Degradation (Catabolism) Digestion Amino-Acid Degradation Inside of cells Urea Cycle – dealing with the nitrogen Protein turnover Ubiquitin Feeding the Urea Cycle Activation-E1 Glucose-Alanine Cycle Conjugation-E2 Free Ammonia Ligation-E3 Proteosome Glutamine Amino-Acid Degradation Glutamate dehydrogenase Ammonia Overall energetics free Dealing with the carbon transamination-mechanism to know Seven Families Urea Cycle – dealing with the nitrogen 1. ADENQ 5 Steps 2. RPH Carbamoyl-phosphate synthetase oxidase Ornithine transcarbamylase one-carbon metabolism Arginino-succinate synthetase THF Arginino-succinase SAM Arginase 3. GSC Energetics PLP uses Urea Bi-cycle 4. MT – one carbon metabolism 5. FY – oxidases Amino Acid Catabolism: Urea Cycle The Urea Bi-Cycle Two issues: 1) What to do with the fumarate? 2) What are the sources of the free ammonia? a-ketoglutarate a-amino acid Aspartate transaminase transaminase a-keto acid Glutamate 1 Amino Acid Catabolism: Urea Cycle The Glucose-Alanine Cycle • Vigorously working muscles operate nearly anaerobically and rely on glycolysis for energy. a-Keto acids • Glycolysis yields pyruvate. – If not eliminated (converted to acetyl- CoA), lactic acid will build up. • If amino acids have become a fuel source, this lactate is converted back to pyruvate, then converted to alanine for transport into the liver. Excess Glutamate is Metabolized in the Mitochondria of Hepatocytes Amino Acid Catabolism: Urea Cycle Excess glutamine is processed in the intestines, kidneys, and liver. (deaminating) (N,Q,H,S,T,G,M,W) OAA à Asp Glutamine Synthetase This costs another ATP, bringing it closer to 5 (N,Q,H,S,T,G,M,W) 29 N 2 Amino Acid Catabolism: Urea Cycle Excess glutamine is processed in the intestines, kidneys, and liver.
  • Amino&Acid&Metabolism& (Chapter&21)&

    Amino&Acid&Metabolism& (Chapter&21)&

    BIOCH 765: Biochemistry II Spring 2014 Amino&Acid&Metabolism& (Chapter&21)& Jianhan&Chen& Office&Hour:&MF&1:30A2:30PM,&Chalmers&034& Email:&[email protected]& Office:&785A2518& Overview& • IntroducPon&to&amino&acids&and&proteins&(1)& • Protein&degradaPon&(1)& • Amino&acid&deaminaPon&(1)& • The&urea&cycle&(1)& • Breakdown&of&amino&acids&(2)& • Amino&acid&synthesis&(1)& • Nitrogen&fiXaPon&(1)& • Key&reference:&Chapter&21&& &&&&&of&Voet,&Voet&&&Pra\&(and& &&&&&this&lecture&note/google)& (c)&Jianhan&Chen& 2& Overview&of&Metabolism& • Metabolism is the sum/total of all the biochemical reactions that take place in a living organism. • Catabolism is all metabolic reactions in which large biochemical molecules are broken down to smaller ones, thus generating energy. • Anabolism is all metabolic reactions in which small biochemical molecules are joined to form larger ones through consumption of energy. catabolism + energy anabolism 3 Major&Stages&of&Catabolism& 4 Insert: macromolecule anabolism Plants start with Biosynthetic pathways always differ from catabolic pathways. 5 Summary of Protein/Amino Acid Body Proteins (protein turnover) Metabolism Amino alcohols Hormones Heme Dietary Proteins Amino Acids Purines (digestion) Pyrimidines degradation Neurotransmitters Nucleotides Glucose + Pyruvate Carbon skeletons NH4 Urea Acetyl Citric Acid cholesterol ATP CoA cycle Fatty acids Ketone bodies 6 Chapter&21&A&1& 1.#PROTEIN#DEGRADATION# Key#Concepts#21.1## •&EXtracellular&and&intracellular&proteins&may&be&digested&by&lysosomal&proteases.& •&Other&proteins&to&be&degraded&are&first&conjugated&to&the&protein&ubiquiPn.&
  • Identification of Novel Monoamine Oxidase B Inhibitors from Ligand Based Virtual Screening

    Identification of Novel Monoamine Oxidase B Inhibitors from Ligand Based Virtual Screening

    Identification of novel monoamine oxidase B inhibitors from ligand based virtual screening A thesis submitted to Kent State University in partial Fulfillment of the requirements for the Degree of Master of Science By Mohammed Alaasam August, 2014 Thesis written by Mohammed Alaasam B.S., University of Baghdad, 2007 M.S., Kent State University, 2014 Approved by Werner Geldenhuys , Chair, Master’s Thesis Committee Richard Carroll , Member, Master’s Thesis Committee Prabodh Sadana , Member, Master’s Thesis Committee Eric Mintz , Director, School of Biomedical Sciences James Blank , Dean, College of Arts and Sciences ii Table of Contents List of figure ...................................................................................................................... vi List of tables ..................................................................................................................... xiii Acknowledgments............................................................................................................ xiv Chapter one: Introduction ............................................................................................... 1 1.1.Parkinson's disease ....................................................................................................... 1 1.2.Monoamine oxidase enzymes ....................................................................................... 7 1.3.Structures of MAO enzymes ....................................................................................... 12 1.4.Three dimentiona